6:25 PM
Dec 12, 2012
 |  BC Extra  |  Company News

Bayer submits MAA for radium-223 for CRPC

Bayer AG (Xetra:BAYN) submitted an MAA to EMA for radium-223 dichloride (formerly Alpharadin) to treat castration-resistant prostate cancer...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >